Vertex Pharmaceuticals Inc
BMV:VRTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
|
W
|
Williams Companies Inc
XBER:WMB
|
US |
|
Hotai Motor Co Ltd
TWSE:2207
|
TW |
|
N
|
Newmont Corporation
F:NMM
|
US |
|
F
|
First Citizens BancShares Inc (Delaware)
F:FC6A
|
US |
|
J
|
Just Eat Takeaway.com NV
XMUN:T5W
|
NL |
Wall St Price Targets
VRTX Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
VRTX is 9 321.07 MXN with a low forecast of 5 539.21 MXN and a high forecast of 11 185.62 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VRTX's stock price target?
Price Target
9 321.07
MXN
According to Wall Street analysts, the average 1-year price target for
VRTX is 9 321.07 MXN with a low forecast of 5 539.21 MXN and a high forecast of 11 185.62 MXN.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 3 years is 18%.